VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLXThe Clorox Company
$97.09$11.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLXBalance Sheet

The Clorox Company (CLX) Balance Sheet

30Y historyFree accessUpdated daily

The company's financial position has deteriorated significantly, evidenced by a negative equity base of $67 million and a debt-to-equity ratio that spiked to 48.76 in 2026Q3.

CLX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Total Current Assets2.65B1.61B1.62B1.83B1.73B1.83B2.02B1.3B1.31B1.51B1.49B1.43B1.4B1.42B1.38B1.28B1.12B1.18B1.25B1.03B1.01B1.09B1.04B951M1B1.1B1.45B1.12B798.7M673.5M573.8M
Cash & Short-Term Investments1.19B167M202M367M183M319M871M111M131M418M401M382M329M299M267M259M87M206M214M182M192M293M232M172M177M251M245M132M89.7M101M90.8M
Cash Only1.19B167M202M367M183M319M871M111M131M418M401M382M329M299M267M259M87M206M214M182M192M293M232M172M177M251M245M132M89.7M101M90.8M
Short-Term Investments0000000000000000000000000000000
Accounts Receivable671M821M695M688M681M604M648M631M600M565M569M519M546M580M576M525M540M486M505M460M435M411M460M463M483M514M633M610M428.5M357M315.1M
Days Sales Outstanding38.6942.1835.7633.9934.9730.0335.1937.0635.7634.5336.0533.536.1437.6538.4536.6337.6632.5534.9634.6434.1934.1938.8340.7843.4148.0756.5955.6257.0551.4551.86
Inventory588M523M637M696M755M752M454M512M506M459M443M385M386M394M384M382M367M366M384M309M292M323M301M264M258M281M376M319M211.9M170.3M138.8M
Days Inventory Outstanding55.1248.8257.1556.2359.765.9845.1953.3553.3850.6651.1943.9744.4444.6644.0946.9946.143.4645.4840.8539.6247.2146.0343.3140.844.2366.9865.373.3262.3456.88
Other Current Assets205M97M88M77M0000000104M92M106M106M113M530M122M150M81M88M63M50M52M134M57M200M55M91M45.2M29.1M
Total Non-Current Assets3.79B3.95B4.13B4.12B4.43B4.5B4.19B3.81B3.75B3.06B3.03B2.73B2.86B2.89B2.98B2.88B3.43B3.4B3.46B2.63B2.61B2.53B2.79B2.7B2.63B2.89B2.9B3.02B2.23B2.1B1.61B
Property, Plant & Equipment1.59B1.6B1.68B1.69B1.68B1.63B1.39B1.03B996M931M906M918M977M1.02B1.08B1.04B979M955M960M976M1B999M1.05B1.07B922M1.05B1.08B1.05B596.3M570.6M551.4M
Fixed Asset Turnover4.24x4.44x4.23x4.37x4.24x4.49x4.82x6.01x6.15x6.42x6.36x6.16x5.64x5.51x5.06x5.03x5.35x5.71x5.49x4.97x4.63x4.39x4.11x3.87x4.40x3.73x3.78x3.80x4.60x4.44x4.02x
Goodwill1.23B1.23B1.23B1.25B1.56B1.57B1.58B1.59B1.6B1.2B1.2B1.07B1.1B1.1B1.11B1.07B1.65B1.63B1.66B855M744M0000000000
Intangible Assets49M566M681M712M884M918M894M912M929M722M735M585M611M627M642M633M646M662M683M348M604M599M1.38B1.38B1.3B1.57B1.54B1.5B1.52B1.19B704.7M
Long-Term Investments0000000000000000000000000000000
Other Non-Current Assets917M558M545M462M315M378M328M274M222M210M187M165M174M138M144M142M144M149M158M186M257M186M364M248M306M272M284M465M442M346.9M349M
Total Assets6.44B5.56B5.75B5.95B6.16B6.33B6.21B5.12B5.06B4.57B4.52B4.16B4.26B4.31B4.36B4.16B4.55B4.58B4.71B3.67B3.62B3.62B3.83B3.65B3.63B4B4.35B4.13B3.03B2.78B2.18B
Asset Turnover1.17x1.28x1.23x1.24x1.15x1.16x1.08x1.21x1.21x1.31x1.28x1.36x1.29x1.30x1.26x1.26x1.15x1.19x1.12x1.32x1.28x1.21x1.13x1.13x1.12x0.98x0.94x0.97x0.90x0.91x1.02x
Asset Growth %14.67%-3.3%-3.26%-3.46%-2.78%1.95%21.44%1.11%10.65%1.22%8.5%-2.21%-1.23%-1.01%4.61%-8.61%-0.46%-2.8%28.42%1.38%-0.03%-5.66%4.98%0.61%-9.14%-8.22%5.35%36.37%9.07%27.5%14.28%
Total Current Liabilities3.15B1.92B1.57B1.92B1.78B2.06B1.42B1.44B1.2B1.81B1.56B1.41B1.64B1.13B2.06B1.36B1.65B1.94B1.66B1.43B1.13B1.35B1.27B1.45B1.23B1.07B1.54B1.37B1.23B892.7M623.9M
Accounts Payable0838M950M1.02B960M930M575M507M507M501M490M431M440M413M412M423M409M381M418M329M329M347M310M312M330M314M378M206M226M143.4M155.4M
Days Payables Outstanding66.3878.2385.2482.4875.9181.657.2352.8353.4855.356.6249.2250.6646.8247.352.0451.3745.2449.543.4944.6450.7247.451.1852.1949.4267.3442.1778.252.4963.68
Short-Term Debt1.68B4M4M50M237M300M0396M199M804M523M395M718M202M1.15B459M671M998M755M574M308M361M291M574M332M319M773M741M778M373.5M193M
Deferred Revenue (Current)0000000000000000000000000000000
Other Current Liabilities1.48B179M190M262M176M219M288M158M154M162M192M189M119M155M165M000017M19M26M24M28M54M036M421M377M375.8M275.5M
Current Ratio0.84x0.84x1.03x0.95x0.97x0.89x1.42x0.91x1.09x0.84x0.95x1.02x0.85x1.25x0.67x0.94x0.68x0.61x0.75x0.72x0.89x0.81x0.82x0.66x0.82x1.03x0.94x0.82x0.65x0.75x0.92x
Quick Ratio0.65x0.57x0.63x0.59x0.54x0.52x1.10x0.55x0.67x0.58x0.67x0.74x0.62x0.90x0.48x0.66x0.46x0.42x0.52x0.51x0.63x0.57x0.59x0.47x0.61x0.77x0.70x0.58x0.48x0.56x0.70x
Cash Conversion Cycle27.4312.787.687.7318.7614.4123.1537.5835.6629.8930.6228.2529.9235.535.2331.5932.3830.7730.933229.1730.6837.4532.9132.0342.8756.2378.7552.1861.345.06
Total Non-Current Liabilities3.19B3.16B3.69B3.64B3.65B3.69B3.89B3.12B3.13B2.22B2.66B2.64B2.47B3.03B2.43B2.88B2.83B2.81B3.42B2.07B2.64B2.82B1.03B986M1.05B1.03B1.02B1.19B719.8M849.3M622.2M
Long-Term Debt2.81B2.48B2.48B2.48B2.47B2.48B2.78B2.29B2.28B1.39B1.79B1.8B1.59B2.17B1.57B2.13B2.12B2.15B2.72B1.46B1.97B2.12B475M495M678M685M590M702M704M565.9M356.3M
Capital Lease Obligations591M305M334M310M314M301M278M000000000000000000000000
Deferred Tax Liabilities82M20M22M28M66M67M62M50M72M61M82M95M103M119M119M140M24M23M97M90M129M82M174M115M142M147M224M237M200.4M170.7M148.4M
Other Non-Current Liabilities356M351M848M825M791M834M767M780M778M770M784M750M768M742M739M619M677M640M632M516M547M618M377M376M231M194M204M255M228M112.7M117.5M
Total Liabilities6.34B5.08B5.26B5.56B5.43B5.74B5.3B4.56B4.33B4.03B4.22B4.05B4.1B4.17B4.49B4.25B4.47B4.75B5.08B3.5B3.77B4.17B2.29B2.44B2.28B2.1B2.56B2.56B1.94B1.74B1.25B
Total Debt4.49B2.88B2.9B2.92B3.1B3.17B3.12B2.68B2.48B2.19B2.31B2.19B2.31B2.37B2.72B2.58B2.79B3.15B3.48B2.04B2.27B2.48B766M1.07B1.01B1B1.36B1.44B1.48B939.4M549.3M
Net Debt3.3B2.71B2.7B2.56B2.92B2.85B2.25B2.57B2.35B1.78B1.91B1.81B1.98B2.07B2.45B2.33B2.71B2.94B3.26B1.85B2.08B2.19B534M897M833M753M1.11B1.31B1.38B838.4M458.5M
Debt / Equity48.76x5.98x5.90x7.54x4.26x5.35x3.44x4.80x3.42x4.05x7.78x18.57x15.02x16.25x--33.67x--11.91x--0.50x0.88x0.75x0.53x0.76x0.92x1.37x0.91x0.59x
Debt / EBITDA3.45x2.06x2.52x2.75x3.37x2.19x2.16x2.08x1.92x1.71x1.88x1.87x2.03x2.09x2.58x2.41x2.40x2.56x3.17x1.93x2.28x2.51x0.72x1.02x1.07x1.20x1.39x1.64x2.19x1.58x1.03x
Net Debt / EBITDA2.54x1.94x2.35x2.41x3.17x1.97x1.56x2.00x1.82x1.38x1.55x1.54x1.74x1.82x2.33x2.16x2.32x2.39x2.97x1.76x2.09x2.21x0.50x0.86x0.88x0.90x1.13x1.49x2.04x1.41x0.86x
Interest Coverage10.38x11.67x4.86x3.31x7.26x10.68x13.74x12.25x14.24x13.60x12.99x10.69x9.93x8.17x7.43x5.58x6.79x6.04x5.13x7.58x6.14x10.23x---------
Total Equity92M482M492M388M729M592M908M559M726M542M297M118M154M146M-135M-86M83M-175M-370M171M-156M-553M1.54B1.22B1.35B1.9B1.79B1.57B1.09B1.04B932.8M
Equity Growth %-163.08%-2.03%26.8%-46.78%23.14%-34.8%62.43%-23%33.95%82.49%151.69%-23.38%5.48%208.15%-56.98%-203.61%147.43%52.7%-316.37%209.62%71.79%-135.91%26.75%-10.27%-28.74%5.91%14.27%44.67%4.75%11.06%-1.18%
Book Value per Share0.763.883.943.125.884.657.114.315.524.122.250.891.171.10-1.02-0.620.59-1.24-2.611.11-1.02-3.097.185.515.777.937.496.545.234.924.51
Total Shareholders' Equity-67M321M328M220M556M411M908M559M726M542M297M118M154M146M-135M-86M83M-175M-370M171M-156M-553M1.54B1.22B1.35B1.9B1.79B1.57B1.09B1.04B932.8M
Common Stock131M131M131M131M131M131M159M159M159M159M159M159M159M159M159M159M159M159M159M159M250M250M250M250M250M250M250M250M000
Retained Earnings223M432M250M583M1.05B1.04B3.57B3.15B2.8B2.44B2.16B1.92B1.74B1.56B1.35B1.14B920M640M386M185M3.94B3.68B2.85B2.56B2.27B2.14B2.07B1.84B1.38B1.21B1.08B
Treasury Stock0-1.4B-1.19B-1.25B-1.35B-1.4B-3.31B-3.19B-2.66B-2.44B-2.32B-2.24B-2.04B-1.87B-1.88B-1.77B-1.24B-1.21B-1.27B-445M-4.53B-4.46B-1.57B-1.51B-1.07B-441M-451M-392M-392M00
Accumulated OCI-152M-157M-155M-493M-479M-546M-640M-602M-547M-543M-570M-502M-417M-367M-396M-250M-371M-347M-179M-209M-215M-352M-287M-348M-318M-246M-200M-180M-612.4M-474.8M-409.8M
Minority Interest159M161M164M168M173M181M0000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowDeteriorating
Top Statement Risk

Excessive leverage and thin equity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Eroding Equity Base Signals Instability

As reported in recent financial statements, Clorox's equity position has deteriorated significantly, shifting from a positive $321 million in 2025Q4 to a negative $67 million by 2026Q3, which highlights a concerning trend of capital erosion that warrants close monitoring by long-term institutional investors.

The rapid depletion of equity suggests that the company's recent earnings performance and capital allocation decisions have failed to preserve shareholder value. This trajectory indicates that the balance sheet is becoming increasingly reliant on debt to sustain operations, which may limit future financial flexibility.

Leverage Metrics Reflect Heightened Risk

Based on the latest quarterly data, the company's debt-to-equity ratio has surged to an alarming 48.76 in 2026Q3, a stark contrast to the 5.98 reported in 2025Q4, suggesting that the firm's reliance on external financing has reached a level that may constrain future strategic initiatives.

The dramatic spike in leverage appears to be driven by both rising debt levels and a shrinking equity base, creating a precarious financial structure. Investors should consider whether this level of indebtedness is sustainable given the current volatility in operating cash flows and the potential for higher interest expenses.

Tight Liquidity Buffers Limit Flexibility

According to recent SEC filings, the current ratio has consistently remained below 1.0, reaching 0.84 in 2026Q3, which indicates that the company may face challenges in meeting its short-term obligations without relying on external credit facilities or further debt issuance to bridge the gap.

A current ratio consistently below unity suggests that current assets are insufficient to cover current liabilities, pointing to a structural liquidity constraint. This lack of a safety buffer may leave the company vulnerable to unexpected operational disruptions or sudden shifts in the credit environment.

Asset Composition Remains Capital Intensive

As indicated by the provided balance sheet data, net property, plant, and equipment have remained stagnant at approximately $1.6 billion over the last ten quarters, while goodwill remains fixed at $1.2 billion, reflecting a business model that requires significant ongoing capital investment to maintain its market position.

The high concentration of goodwill relative to total assets suggests that the company's valuation is heavily dependent on past acquisitions, which may be subject to impairment risk if the underlying business units underperform. The lack of growth in net PPE further implies that capital expenditures are primarily focused on maintenance rather than expansion.

CLX — Frequently Asked Questions

Quick answers to the most common questions about buying CLX stock.

What are the total assets of The Clorox Company (CLX)?

As of 2025, The Clorox Company (CLX) had total assets of $5.56B including $1.61B in current assets.

How much debt does The Clorox Company (CLX) have?

The Clorox Company (CLX) carries total debt of $2.88B, offset by $167.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of The Clorox Company?

The Clorox Company (CLX) has total shareholders' equity (book value) of $321.0M ($3.88 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is The Clorox Company's current ratio and liquidity?

The Clorox Company (CLX) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.